Rhabdomyolysis is caused by extensive damage to skeletal muscles resulting in elevated creatine phosphokinase (CPK), Lactate dehydrogenase (LDH), and aspartate aminotransferase (AST), leading to life-threatening consequences like acute renal failure, cardiac arrhythmias, and hyperthermia. A variety of causes for muscle damage are known, and one of the most common is drug-induced. Statins and many other agents are known to induce muscle damage, but here we report Entresto™ (Sacubitril/Valsartan) induced rhabdomyolysis which has not been previously reported as solely responsible in the literature.
CITATION STYLE
Rawla, P., Raj, J. P., George, S. M., Nathala, P., & Vellipuram, A. R. (2019). A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan. Diseases, 7(2), 38. https://doi.org/10.3390/diseases7020038
Mendeley helps you to discover research relevant for your work.